Drug Eluting Balloon Market is expected to reach USD 2.61 Bn. during the forecast period 2030, as reported by Maximize Market Research

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The total global market for the "Drug Eluting Balloon Market" was valued at USD 1.84 Bn. in 2023 and is expected to grow at a CAGR of 5.1 percent over the forecast period to reach USD 2.61 Bn by 2030. A report published by Maximize Market Research, on the Drug Eluting Balloon Market, is explained based on different segmentations.

The drug-eluting balloons (DEB) are the substitutes for drug-eluting stents (DES) for the in-stent restenosis (ISR) treatment. The polymeric matrix containing antiproliferative drugs gets released in a vessel wall during the balloon inflation. The market is segmented based on product, technology, end-user, and region.

𝐍𝐞𝐞𝐝 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 + 𝐆𝐫𝐚𝐩𝐡𝐬 𝐇𝐞𝐫𝐞:https://www.maximizemarketresearch.com/request-sample/40237/

Based on the product it can be coronary DEB for coronary artery diseases, peripheral DEB for peripheral artery diseases, or others for renal or vascular diseases. By technology paclitaxel-eluting balloons are most common, used for inhibiting tissue growth after stent placement. End-users can be hospitals, ambulatory surgical centers, and catheterization laboratories.

Regionally North America dominates the drug eluting balloons market. The prevalence of cardiovascular disease due to lifestyle and obesity, a strong healthcare sector with high spending on R&D, and early adoption of technology sets the North American region apart. Europe is showing considerable growth as the aging population and supportive healthcare policies are supporting the European drug eluting balloons market growth. The cardiovascular diseases have become the leading cause of death, with 17.9 million deaths per year, which is around 32% of all deaths globally. More than three-quarters of CVD (cardiovascular disease) deaths are reported in low and middle-income countries.

The shift towards minimal invasion devices and procedures with technological advancements in DEB technology are driving the market. The higher cost of DEB and stringent regulatory requirements are restraints faced by the drug eluting balloons market. The limited awareness of DEB and competing technology such as stents are a challenge. With the number of deaths each year, developing countries are increasing the investment in healthcare infrastructure, offering an opportunity to the DEB manufacturers.

September 19, 2022, SirPlux Duo coronary DCB received approval from US FDA, for coronary artery disease in vessels less than 3mm.
October 18, 2022- Cordis announced acquisition of MedAlliance, as Swiss develop of DEB to improve coronary and peripheral vascular product portfolio.

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐭𝐨 𝐩𝐞𝐞𝐤 𝐢𝐧𝐬𝐢𝐝𝐞? 𝐆𝐫𝐚𝐛 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐰:https://www.maximizemarketresearch.com/request-sample/40237/ 

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others

𝐁𝐲 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

Paccocath
Free Pac
transPax
Enduracoat
Others

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫

Hospital and Ambulatory Surgery
Centers
Cath Laboratories
Others

𝐘𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐈𝐬 𝐉𝐮𝐬𝐭 𝐚 𝐂𝐥𝐢𝐜𝐤 𝐀𝐰𝐚 :https://www.maximizemarketresearch.com/request-sample/40237/

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Medtronic, Inc.
Becton, Dickinson and Company
Boston Scientific Corporation
Cook Medical Incorporated
Braun Melsungen AG
Koninklijke Philips N.V.
Opto Circuits (India) Limited
Terumo Corporation
Surmodics, Inc.
Biotronik, Inc.
Concept Medical Inc.
BIOTRONIK SE & Co. KG
Innvolution Healthcare Pvt. Ltd.
Medtronic plc
Eurocor GmbH
C.R. Bard
Aachen Resonance GmbH

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.maximizemarketresearch.com/market-report/global-drug-eluting-balloon-market/40237/

𝐊𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

What was the Drug Eluting Balloon Market size in 2023?
What is the growth rate of the Drug Eluting Balloon Market?
Which is the most lucrative region in the Drug Eluting Balloon Market during forecast period?
Which segment dominates the Drug Eluting Balloon Market?

𝐊𝐞𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬:

Past Market Size and Competitive Landscape Drug Eluting Balloon Market (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by segment with their sub-segments and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations

𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐬 𝐚 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐟𝐢𝐫𝐦, 𝐡𝐚𝐬 𝐚𝐥𝐬𝐨 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐫𝐞𝐩𝐨𝐫𝐭𝐬:

♦ Asia Pacific Scr Power Controller Market https://www.maximizemarketresearch.com/market-report/asia-pacific-scr-power-controller-market/6875/

♦ Asia Pacific Sheet Face Mask Market https://www.maximizemarketresearch.com/market-report/asia-pacific-sheet-face-mask-market/21825/

♦ Asia Pacific Smart Fleet Management Market https://www.maximizemarketresearch.com/market-report/asia-pacific-smart-fleet-management-market/3155/

♦ Astaxanthin Market https://www.maximizemarketresearch.com/market-report/astaxanthin-market/187849/

♦ Atelocollagen Market https://www.maximizemarketresearch.com/market-report/atelocollagen-market/146421/

♦ Audio Codec Market https://www.maximizemarketresearch.com/market-report/audio-codec-market/188963/

♦ Australia Electric Car Market https://www.maximizemarketresearch.com/market-report/australia-electric-car-market/65405/

♦ Autologous Cell Therapy Market https://www.maximizemarketresearch.com/market-report/autologous-cell-therapy-market/171125/

♦ Automated 3D Printing Market https://www.maximizemarketresearch.com/market-report/automated-3d-printing-market/129810/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.